
London cell-free biomanufacturing startup FabricNano has secured $12.5 million in a Series A funding round led by Atomico, with participation from existing investors Backed, Hoxton Ventures, and Entrepreneur First, as well as a long list of angel investors. The round brings the total amount raised by FabricNano to $16 million.
The goal of FabricNano’s technology is to make biomanufacturing — that is, using biological systems to produce certain materials — scalable and efficient. Cell-free biomanufacturing, which the company focuses on, means that “living cells are removed from the biomanufacturing process and replaced with enzymes,” the company explained in an announcement.
The startup didn’t invent cell-free biomanufacturing, but says that it has made it commercially viable thanks to “the high purity of its bioproducts that require little to no downstream processing, which accounts for approximately 25% of chemical manufacturing costs.”
FabricNano said that it will use the fresh funding “to advance the development of sustainably synthesised alternatives to petrochemical products such as plastics, perfume fragrances, and drugs, which currently account for 14% of global oil demand.”
2 comments
16484 463185I discovered your weblog web site on google and examine a number of of your early posts. Continue to maintain up the superb operate. I just extra up your RSS feed to my MSN News Reader. In search of forward to reading more from you later on! 191499
50743 193634my grandmother is always into herbal stuffs and she always say that ayurvedic medicines are the most effective stuff 791885